Current Assets
Inventories
Gilead Sciences Inventories decreased by 6.6% to $2.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.1%, from $2.02B to $2.42B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 14.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
Rising inventory levels may signal anticipated demand growth or, conversely, a slowdown in sales and potential product obsolescence.
Detailed definition
This includes the value of raw materials, work-in-progress, and finished pharmaceutical products held for sale. It repre...
Peer comparison
Standard across manufacturing and life sciences; peers monitor this closely to manage shelf-life risks.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.22B | $1.12B | $1.12B | $1.19B | $1.09B | $1.14B | $1.31B | $1.43B | $1.55B | $1.54B | $1.58B | $1.51B | $1.36B | $1.57B | $1.88B | $2.02B | $2.09B | $2.6B | $2.59B | $2.42B |
| QoQ Change | — | -7.8% | -0.4% | +7.0% | -8.4% | +4.0% | +15.4% | +9.2% | +7.9% | -0.5% | +2.5% | -4.3% | -9.8% | +15.0% | +20.0% | +7.4% | +3.4% | +24.7% | -0.3% | -6.6% |
| YoY Change | — | — | — | — | -10.0% | +1.5% | +17.7% | +20.1% | +41.4% | +35.2% | +20.2% | +5.3% | -12.0% | +1.8% | +19.1% | +33.6% | +53.2% | +66.2% | +38.1% | +20.1% |
Range$1.09B – $2.6B
CAGR+15.6%
Avg YoY Growth+22.0%
Median YoY Growth+20.1%
Current Streak2 quarters decline
Inventories at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's inventories?
- Gilead Sciences (GILD) reported inventories of $2.42B in Q1 2026.
- How has Gilead Sciences's inventories changed year-over-year?
- Gilead Sciences's inventories increased by 20.1% year-over-year, from $2.02B to $2.42B.
- What is the long-term trend for Gilead Sciences's inventories?
- Over 5 years (2020 to 2025), Gilead Sciences's inventories has grown at a 14.3% compound annual growth rate (CAGR), from $1.33B to $2.59B.
- What does inventories mean?
- The total value of all unsold products and materials currently held by the company.